Aketa, Naohiko
Uchino, Miki
Kawashima, Motoko
Uchino, Yuichi
Yuki, Kenya
Ozawa, Yoko
Sasaki, Mariko
Yamagishi, Kazumasa
Sawada, Norie
Tsugane, Shoichiro
Tsubota, Kazuo
Iso, Hiroyasu
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP16K11271)
Novartis Research Grant
National Cancer Center Japan
Article History
Received: 8 May 2020
Accepted: 3 March 2021
First Online: 18 March 2021
Competing interests
: The authors declare no competing interests. Kazuo Tsubota reports his position as CEO of Tsubota Laboratory, Inc., Tokyo, Japan, a company producing myopia-related devices.